(Q36615933)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17024156%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17024156%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17024156%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Vincent Goffin

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17024156%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Philippe Touraine

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17024156%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Paul A Kelly

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17024156%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17024156%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Endocrinology and Metabolism

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17024156%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17024156%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17024156%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

571-581

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17024156%20AND%20SRC:MED&resulttype=core&format=json

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

Are chronic psychiatric patients at increased risk for developing breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

Medical management of prolactin-secreting pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Increase in bone mass after treatment of hyperprolactinemic amenorrhea

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Pituitary tumors: pathophysiology, clinical manifestations and management

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Dopamine resistance of prolactinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Development and potential clinical uses of human prolactin receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Rational design of potent antagonists to the human growth hormone receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Zinc mediation of the binding of human growth hormone to the human prolactin receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Model for growth hormone receptor activation based on subunit rotation within a receptor dimer

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo- and hetero-pairs of long and short human PRL receptors in living human cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Mechanism for ordered receptor binding by human prolactin

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

New homologous bioassays for human lactogens show that agonism or antagonism of various analogs is a function of assay sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Development of pure prolactin receptor antagonists.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

1 reference

7 January 2021

Hyperprolactinemia: etiology, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Management of prolactinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

The role of prolactin in mammary carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Prolactin involvement in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Prolactin as a mitogen in mammary cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Involvement of prolactin in breast cancer: redefining the molecular targets.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Should prolactin be reconsidered as a therapeutic target in human breast cancer?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Prolactin and breast cancer risk

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Plasma prolactin concentrations and risk of postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Prolactin specifically activates signal transducer and activator of transcription 5b in neuroendocrine dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Prolactin-regulated tyrosine hydroxylase activity and messenger ribonucleic acid expression in mediobasal hypothalamic cultures: the differential role of specific protein kinases

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Prolactin: structure, function, and regulation of secretion

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Clinical review 166: Growth hormone receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Hyperprolactinaemia and antipsychotic therapy in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Prolactin secretion in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Tolerance to the prolactin-elevating effect of neuroleptics

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Antipsychotics: impact on prolactin levels

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Bone mineral density and prolactin associations in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Dopamine antagonists and the development of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Medication-induced hyperprolactinemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

The effect of atypical antipsychotic agents on prolactin levels in children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

PRL modulates cell cycle regulators in mammary tumor epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Prolactin and prolactin receptors are expressed and functioning in human prostate

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Expression of prolactin and its receptor in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Gene expression profiles of poor-prognosis primary breast cancer correlate with survival

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Cellular expression of growth hormone and prolactin receptors in human breast disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Transcription of the human prolactin gene in mammary cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Solution Structure of Human Prolactin

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0270

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17024156%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference